Medvi leads with an ongoing monthly rate, $299 per month for compounded semaglutide and $399 per month for compounded tirzepatide (as captured July 2026), with no membership fee on the compounded program
We need to wait and see if the FDA decides whether or not to follow the committees recommendations
PMCID: PMC49146
Both medications offer a wide range of long-term health improvements, including: Improved blood sugar control : Both drugs help manage blood sugar levels in people with type 2 diabetes, which can prevent complications like neuropathy, kidney disease, and vision loss
If your period is more than a week late and you are sexually active, we recommend taking a pregnancy test
Mounjaro is not currently licensed specifically for the treatment of hypertriglyceridaemia (elevated triglycerides), and it should not be prescribed solely for lipid management